{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:56:12Z","timestamp":1793224572530,"version":"4.5.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T00:00:00Z","timestamp":1287100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00018-010-0525-1","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T11:18:21Z","timestamp":1287055101000},"page":"931-949","source":"Crossref","is-referenced-by-count":163,"title":["Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases"],"prefix":"10.1007","volume":"68","author":[{"given":"Merouane","family":"Bencherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Lippiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario B.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,15]]},"reference":[{"key":"525_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/187152908786786188","volume":"8","author":"R Haverslag","year":"2008","unstructured":"Haverslag R, Pasterkamp G, Hoefer IE (2008) Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 8:252\u2013260","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"525_CR2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125:S3\u2013S23","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR3","doi-asserted-by":"crossref","first-page":"674363","DOI":"10.1155\/2010\/674363","volume":"2010","author":"M Loiarro","year":"2010","unstructured":"Loiarro M, Ruggiero V, Sette C (2010) Targeting TLR\/IL-1R signalling in human diseases. Mediators Inflamm 2010:674363","journal-title":"Mediators Inflamm"},{"key":"525_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000315915","volume":"167","author":"SM Opal","year":"2010","unstructured":"Opal SM (2010) Endotoxins and other sepsis triggers. Contrib Nephrol 167:14\u201324","journal-title":"Contrib Nephrol"},{"key":"525_CR5","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jaci.2009.07.008","volume":"125","author":"SP Commins","year":"2010","unstructured":"Commins SP, Borish L, Steinke JW (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 125:S53\u2013S72","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","volume":"78","author":"AH Sprague","year":"2009","unstructured":"Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539\u2013552","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 7","key":"525_CR7","first-page":"19","volume":"60","author":"L Duvnjak","year":"2009","unstructured":"Duvnjak L, Duvnjak M (2009) The metabolic syndrome\u2014an ongoing story. J Physiol Pharmacol 60(Suppl 7):19\u201324","journal-title":"J Physiol Pharmacol"},{"key":"525_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219\u2013246","journal-title":"Annu Rev Physiol"},{"key":"525_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000289203","volume":"11","author":"T Tzanavari","year":"2010","unstructured":"Tzanavari T, Giannogonas P, Karalis KP (2010) TNF-alpha and obesity. Curr Dir Autoimmun 11:145\u2013156","journal-title":"Curr Dir Autoimmun"},{"key":"525_CR10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/db07-1344","volume":"58","author":"P Jiao","year":"2009","unstructured":"Jiao P, Chen Q, Shah S, Du J, Tao B, Tzameli I, Yan W, Xu H (2009) Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-kappaB and c-Jun NH2-terminal kinase pathways. Diabetes 58:104\u2013115","journal-title":"Diabetes"},{"key":"525_CR11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"Rabe K, Lehrke M, Parhofer KG, Broedl UC (2008) Adipokines and insulin resistance. Mol Med 14:741\u2013751","journal-title":"Mol Med"},{"key":"525_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","volume":"133","author":"M Filkova","year":"2009","unstructured":"Filkova M, Haluzik M, Gay S, Senolt L (2009) The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol 133:157\u2013170","journal-title":"Clin Immunol"},{"key":"525_CR13","doi-asserted-by":"crossref","first-page":"25569","DOI":"10.1074\/jbc.M109.019786","volume":"284","author":"EJ Folco","year":"2009","unstructured":"Folco EJ, Rocha VZ, Lopez-Ilasaca M, Libby P (2009) Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem 284:25569\u201325575","journal-title":"J Biol Chem"},{"key":"525_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MOL.0b013e32832ac03e","volume":"20","author":"S Devaraj","year":"2009","unstructured":"Devaraj S, Singh U, Jialal I (2009) Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 20:182\u2013189","journal-title":"Curr Opin Lipidol"},{"key":"525_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/bmm.09.89","volume":"4","author":"D Galasko","year":"2010","unstructured":"Galasko D, Montine TJ (2010) Biomarkers of oxidative damage and inflammation in Alzheimer\u2019s disease. Biomark Med 4:27\u201336","journal-title":"Biomark Med"},{"key":"525_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/187152710791012071","volume":"9","author":"S Mandrekar-Colucci","year":"2010","unstructured":"Mandrekar-Colucci S, Landreth GE (2010) Microglia and inflammation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 9:156\u2013167","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"525_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/alzrt29","volume":"2","author":"ZS Tan","year":"2010","unstructured":"Tan ZS, Seshadri S (2010) Inflammation in the Alzheimer\u2019s disease cascade: culprit or innocent bystander? Alzheimers Res Ther 2:6","journal-title":"Alzheimers Res Ther"},{"key":"525_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","volume":"39","author":"LE Rojo","year":"2008","unstructured":"Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer\u2019s disease. Arch Med Res 39:1\u201316","journal-title":"Arch Med Res"},{"key":"525_CR19","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","volume":"118","author":"FM Brennan","year":"2008","unstructured":"Brennan FM, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537\u20133545","journal-title":"J Clin Invest"},{"key":"525_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2009.09.019","volume":"10","author":"JA Jazayeri","year":"2010","unstructured":"Jazayeri JA, Carroll GJ, Vernallis AB (2010) Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists. Int Immunopharmacol 10:1\u20138","journal-title":"Int Immunopharmacol"},{"key":"525_CR21","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1517\/14656566.8.13.2089","volume":"8","author":"E Toussirot","year":"2007","unstructured":"Toussirot E, Wendling D (2007) The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 8:2089\u20132107","journal-title":"Expert Opin Pharmacother"},{"key":"525_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-009-0189-9","volume":"32","author":"E Lubberts","year":"2010","unstructured":"Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32:43\u201353","journal-title":"Semin Immunopathol"},{"key":"525_CR23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2010.02.025","volume":"125","author":"S Lee","year":"2010","unstructured":"Lee S, Ballow M (2010) Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases. J Allergy Clin Immunol 125:814\u2013820","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2007.00506.x","volume":"217","author":"PA Nigrovic","year":"2007","unstructured":"Nigrovic PA, Lee DM (2007) Synovial mast cells: role in acute and chronic arthritis. Immunol Rev 217:19\u201337","journal-title":"Immunol Rev"},{"key":"525_CR25","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.0610852103","volume":"104","author":"PA Nigrovic","year":"2007","unstructured":"Nigrovic PA, Binstadt BA, Monach PA, Johnsen A, Gurish M, Iwakura Y, Benoist C, Mathis D, Lee DM (2007) Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA 104:2325\u20132330","journal-title":"Proc Natl Acad Sci USA"},{"key":"525_CR26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233:233\u2013255","journal-title":"Immunol Rev"},{"key":"525_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2009.00853.x","volume":"233","author":"H Uysal","year":"2010","unstructured":"Uysal H, Nandakumar KS, Kessel C, Haag S, Carlsen S, Burkhardt H, Holmdahl R (2010) Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol Rev 233:9\u201333","journal-title":"Immunol Rev"},{"key":"525_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaci.2010.04.006","volume":"126","author":"B Dua","year":"2010","unstructured":"Dua B, Watson RM, Gauvreau GM, O\u2019Byrne PM (2010) Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 126:133\u2013139","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaci.2010.02.011","volume":"125","author":"PG Holt","year":"2010","unstructured":"Holt PG, Strickland DH (2010) Interactions between innate and adaptive immunity in asthma pathogenesis: new perspectives from studies on acute exacerbations. J Allergy Clin Immunol 125:963\u2013972","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR30","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.0902185","volume":"184","author":"FD Finkelman","year":"2010","unstructured":"Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills-Karp M (2010) Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 184:1663\u20131674","journal-title":"J Immunol"},{"key":"525_CR31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jaci.2007.01.015","volume":"119","author":"PJ Barnes","year":"2007","unstructured":"Barnes PJ (2007) New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 119:1055\u20131062","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR32","first-page":"67","volume":"6","author":"AJ Tavakkol","year":"2007","unstructured":"Tavakkol AJ, Farid HR, Hosseini FS, Heydarian F, Boskabady MH, Khoshnavaz R, Razavi A, Ghayoor KE, Ghasemi G (2007) Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma. Iran J Allergy Asthma Immunol 6:67\u201372","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"525_CR33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaci.2009.11.048","volume":"125","author":"WW Busse","year":"2010","unstructured":"Busse WW, Ring J, Huss-Marp J, Kahn JE (2010) A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. J Allergy Clin Immunol 125:803\u2013813","journal-title":"J Allergy Clin Immunol"},{"key":"525_CR34","first-page":"1121","volume":"28","author":"F Ribeiro","year":"2009","unstructured":"Ribeiro F, Alves AJ, Teixeira M, Ribeiro V, Duarte JA, Oliveira J (2009) Endothelial function and atherosclerosis: circulatory markers with clinical usefulness. Rev Port Cardiol 28:1121\u20131151","journal-title":"Rev Port Cardiol"},{"key":"525_CR35","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.2741\/3084","volume":"13","author":"E Lubos","year":"2008","unstructured":"Lubos E, Handy DE, Loscalzo J (2008) Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci 13:5323\u20135344","journal-title":"Front Biosci"},{"key":"525_CR36","first-page":"109","volume":"50","author":"G Rodriguez","year":"2009","unstructured":"Rodriguez G, Mago N, Rosa F (2009) Role of inflammation in atherogenesis. Invest Clin 50:109\u2013129","journal-title":"Invest Clin"},{"key":"525_CR37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1423-0127-16-112","volume":"16","author":"P Puddu","year":"2009","unstructured":"Puddu P, Puddu GM, Cravero E, De Pascalis S, Muscari A (2009) The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. J Biomed Sci 16:112","journal-title":"J Biomed Sci"},{"key":"525_CR38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/CS20090488","volume":"118","author":"E McNeill","year":"2010","unstructured":"McNeill E, Channon KM, Greaves DR (2010) Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. Clin Sci (Lond) 118:641\u2013655","journal-title":"Clin Sci (Lond)"},{"key":"525_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","volume":"7","author":"KJ Woollard","year":"2010","unstructured":"Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7:77\u201386","journal-title":"Nat Rev Cardiol"},{"key":"525_CR40","first-page":"263","volume":"14","author":"A Sgambato","year":"2010","unstructured":"Sgambato A, Cittadini A (2010) Inflammation and cancer: a multifaceted link. Eur Rev Med Pharmacol Sci 14:263\u2013268","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"525_CR41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883\u2013899","journal-title":"Cell"},{"key":"525_CR42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156652410791316968","volume":"10","author":"A Mantovani","year":"2010","unstructured":"Mantovani A (2010) Molecular pathways linking inflammation and cancer. Curr Mol Med 10:369\u2013373","journal-title":"Curr Mol Med"},{"key":"525_CR43","first-page":"471","volume":"32","author":"CS Wang","year":"2009","unstructured":"Wang CS, Sun CF (2009) C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J 32:471\u2013482","journal-title":"Chang Gung Med J"},{"key":"525_CR44","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ijc.24923","volume":"126","author":"SE Erdman","year":"2010","unstructured":"Erdman SE, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z, Poutahidis T (2010) Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer 126:1651\u20131665","journal-title":"Int J Cancer"},{"key":"525_CR45","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","volume":"121","author":"A Federico","year":"2007","unstructured":"Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381\u20132386","journal-title":"Int J Cancer"},{"key":"525_CR46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2009.10.006","volume":"125","author":"JL Kreindler","year":"2010","unstructured":"Kreindler JL (2010) Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther 125:219\u2013229","journal-title":"Pharmacol Ther"},{"key":"525_CR47","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.4049\/jimmunol.181.4.2753","volume":"181","author":"B Koller","year":"2008","unstructured":"Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, Kormann M, Kabesch M, Roos D, Griese M, Hartl D (2008) TLR expression on neutrophils at the pulmonary site of infection: TLR1\/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 181:2753\u20132763","journal-title":"J Immunol"},{"key":"525_CR48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1051\/medsci\/2010264405","volume":"26","author":"J Matricon","year":"2010","unstructured":"Matricon J (2010) Immunopathogenesis of inflammatory bowel disease. Med Sci (Paris) 26:405\u2013410","journal-title":"Med Sci (Paris)"},{"key":"525_CR49","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","volume":"14","author":"F Sanchez-Munoz","year":"2008","unstructured":"Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK (2008) Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280\u20134288","journal-title":"World J Gastroenterol"},{"key":"525_CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/187221310791163071","volume":"4","author":"J Wei","year":"2010","unstructured":"Wei J, Feng J (2010) Signaling pathways associated with inflammatory bowel disease. Recent Pat Inflamm Allergy Drug Discov 4:105\u2013117","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"525_CR51","first-page":"389","volume":"63","author":"B Polinska","year":"2009","unstructured":"Polinska B, Matowicka-Karna J, Kemona H (2009) The cytokines in inflammatory bowel disease. Postepy Hig Med Dosw (Online) 63:389\u2013394","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"525_CR52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biocel.2008.10.022","volume":"41","author":"G Tonel","year":"2009","unstructured":"Tonel G, Conrad C (2009) Interplay between keratinocytes and immune cells\u2014recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol 41:963\u2013968","journal-title":"Int J Biochem Cell Biol"},{"issue":"Suppl 2","key":"525_CR53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2133.2008.08780.x","volume":"159","author":"F Spah","year":"2008","unstructured":"Spah F (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159(Suppl 2):10\u201317","journal-title":"Br J Dermatol"},{"key":"525_CR54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.det.2010.03.009","volume":"28","author":"J Mazza","year":"2010","unstructured":"Mazza J, Rossi A, Weinberg JM (2010) Innovative uses of tumor necrosis factor alpha inhibitors. Dermatol Clin 28:559\u2013575","journal-title":"Dermatol Clin"},{"key":"525_CR55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11926-007-0075-1","volume":"9","author":"E Fitch","year":"2007","unstructured":"Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461\u2013467","journal-title":"Curr Rheumatol Rep"},{"key":"525_CR56","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.2174\/138161206778522056","volume":"12","author":"M Ishii","year":"2006","unstructured":"Ishii M, Kurachi Y (2006) Muscarinic acetylcholine receptors. Curr Pharm Des 12:3573\u20133581","journal-title":"Curr Pharm Des"},{"key":"525_CR57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bcp.2009.05.024","volume":"78","author":"C Gotti","year":"2009","unstructured":"Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78:703\u2013711","journal-title":"Biochem Pharmacol"},{"key":"525_CR58","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/092986708786848703","volume":"15","author":"G Sharma","year":"2008","unstructured":"Sharma G, Vijayaraghavan S (2008) Nicotinic receptors containing the alpha7 subunit: a model for rational drug design. Curr Med Chem 15:2921\u20132932","journal-title":"Curr Med Chem"},{"key":"525_CR59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/aps.2009.64","volume":"30","author":"JX Shen","year":"2009","unstructured":"Shen JX, Yakel JL (2009) Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin 30:673\u2013680","journal-title":"Acta Pharmacol Sin"},{"key":"525_CR60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pharmthera.2009.03.009","volume":"122","author":"SC Leiser","year":"2009","unstructured":"Leiser SC, Bowlby MR, Comery TA, Dunlop J (2009) A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 122:302\u2013311","journal-title":"Pharmacol Ther"},{"key":"525_CR61","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","volume":"151","author":"WJ Jonge de","year":"2007","unstructured":"de Jonge WJ, Ulloa L (2007) The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151:915\u2013929","journal-title":"Br J Pharmacol"},{"key":"525_CR62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.FM0070073","volume":"106","author":"K Kawashima","year":"2008","unstructured":"Kawashima K, Fujii T (2008) Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci 106:167\u2013173","journal-title":"J Pharmacol Sci"},{"key":"525_CR63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","volume":"117","author":"KJ Tracey","year":"2007","unstructured":"Tracey KJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289\u2013296","journal-title":"J Clin Invest"},{"key":"525_CR64","first-page":"355","volume":"12","author":"DW Wang","year":"2009","unstructured":"Wang DW, Zhou RB, Yao YM (2009) Role of cholinergic anti-inflammatory pathway in regulating host response and its interventional strategy for inflammatory diseases. Chin J Traumatol 12:355\u2013364","journal-title":"Chin J Traumatol"},{"key":"525_CR65","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10354-010-0761-x","volume":"160","author":"DJ Westerloo van","year":"2010","unstructured":"van Westerloo DJ (2010) The vagal immune reflex: a blessing from above. Wien Med Wochenschr 160:112\u2013117","journal-title":"Wien Med Wochenschr"},{"key":"525_CR66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1797","volume":"4","author":"L Ulloa","year":"2005","unstructured":"Ulloa L (2005) The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 4:673\u2013684","journal-title":"Nat Rev Drug Discov"},{"key":"525_CR67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2119\/2007-00067.Dowling","volume":"13","author":"O Dowling","year":"2007","unstructured":"Dowling O, Rochelson B, Way K, Al-Abed Y, Metz CN (2007) Nicotine inhibits cytokine production by placenta cells via NFkappaB: potential role in pregnancy-induced hypertension. Mol Med 13:576\u2013583","journal-title":"Mol Med"},{"key":"525_CR68","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1084\/jem.20040463","volume":"201","author":"RW Saeed","year":"2005","unstructured":"Saeed RW, Varma S, Peng-Nemeroff T, Sherry B, Balakhaneh D, Huston J, Tracey KJ, Al-Abed Y, Metz CN (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201:1113\u20131123","journal-title":"J Exp Med"},{"key":"525_CR69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1471-4159.2004.02347.x","volume":"89","author":"RD Shytle","year":"2004","unstructured":"Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J (2004) Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 89:337\u2013343","journal-title":"J Neurochem"},{"key":"525_CR70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3858\/emm.2008.40.1.11","volume":"40","author":"JH Moon","year":"2008","unstructured":"Moon JH, Kim SY, Lee HG, Kim SU, Lee YB (2008) Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia. Exp Mol Med 40:11\u201318","journal-title":"Exp Mol Med"},{"key":"525_CR71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2119\/2008-00079.Parrish","volume":"14","author":"WR Parrish","year":"2008","unstructured":"Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, Ochani M, Ochani K, Yang LH, Hudson L, Lin X, Patel N, Johnson SM, Chavan S, Goldstein RS, Czura CJ, Miller EJ, Al-Abed Y, Tracey KJ, Pavlov VA (2008) Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 14:567\u2013574","journal-title":"Mol Med"},{"key":"525_CR72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1365-2796.2009.02098.x","volume":"265","author":"M Rosas-Ballina","year":"2009","unstructured":"Rosas-Ballina M, Tracey KJ (2009) Cholinergic control of inflammation. J Intern Med 265:663\u2013679","journal-title":"J Intern Med"},{"key":"525_CR73","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2006.02.022","volume":"130","author":"DJ Westerloo van","year":"2006","unstructured":"van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der Poll T (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822\u20131830","journal-title":"Gastroenterology"},{"key":"525_CR74","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1086\/430323","volume":"191","author":"DJ Westerloo van","year":"2005","unstructured":"van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der Poll T (2005) The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 191:2138\u20132148","journal-title":"J Infect Dis"},{"key":"525_CR75","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ni1229","volume":"6","author":"WJ Jonge de","year":"2005","unstructured":"de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844\u2013851","journal-title":"Nat Immunol"},{"key":"525_CR76","doi-asserted-by":"crossref","first-page":"E885","DOI":"10.1208\/aapsj070486","volume":"7","author":"LC Gahring","year":"2005","unstructured":"Gahring LC, Rogers SW (2005) Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J 7:E885\u2013E894","journal-title":"AAPS J"},{"key":"525_CR77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00573842","volume":"44","author":"BD Davies","year":"1982","unstructured":"Davies BD, Hoss W, Lin JP, Lionetti F (1982) Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol Cell Biochem 44:23\u201331","journal-title":"Mol Cell Biochem"},{"key":"525_CR78","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/S0028-3908(00)00153-2","volume":"39","author":"K Benhammou","year":"2000","unstructured":"Benhammou K, Lee M, Strook M, Sullivan B, Logel J, Raschen K, Gotti C, Leonard S (2000) [(3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology 39:2818\u20132829","journal-title":"Neuropharmacology"},{"key":"525_CR79","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.lfs.2009.07.010","volume":"85","author":"MJ Rosa De","year":"2009","unstructured":"De Rosa MJ, Dionisio L, Agriello E, Bouzat C, Esandi MC (2009) Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 85:444\u2013449","journal-title":"Life Sci"},{"key":"525_CR80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","volume":"74","author":"C Gotti","year":"2004","unstructured":"Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363\u2013396","journal-title":"Prog Neurobiol"},{"key":"525_CR81","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.intimp.2009.12.001","volume":"10","author":"AI Chernyavsky","year":"2010","unstructured":"Chernyavsky AI, Arredondo J, Skok M, Grando SA (2010) Auto\/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. Int Immunopharmacol 10:308\u2013315","journal-title":"Int Immunopharmacol"},{"key":"525_CR82","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.0902212","volume":"183","author":"E Nizri","year":"2009","unstructured":"Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183:6681\u20136688","journal-title":"J Immunol"},{"key":"525_CR83","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2119\/molmed.2009.00039","volume":"15","author":"M Rosas-Ballina","year":"2009","unstructured":"Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, Valdes-Ferrer SI, Patel NB, Chavan S, Al-Abed Y, Yang H, Tracey KJ (2009) The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15:195\u2013202","journal-title":"Mol Med"},{"key":"525_CR84","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbamcr.2007.12.003","volume":"1783","author":"K Rehani","year":"2008","unstructured":"Rehani K, Scott DA, Renaud D, Hamza H, Williams LR, Wang H, Martin M (2008) Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. Biochim Biophys Acta 1783:375\u2013382","journal-title":"Biochim Biophys Acta"},{"key":"525_CR85","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","volume":"14","author":"H Tilg","year":"2008","unstructured":"Tilg H, Moschen AR (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14:222\u2013231","journal-title":"Mol Med"},{"key":"525_CR86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2007.07.003","volume":"112","author":"M Zeyda","year":"2007","unstructured":"Zeyda M, Stulnig TM (2007) Adipose tissue macrophages. Immunol Lett 112:61\u201367","journal-title":"Immunol Lett"},{"key":"525_CR87","first-page":"241","volume":"99","author":"JA Maasen","year":"2008","unstructured":"Maasen JA (2008) Mitochondria, body fat and type 2 diabetes: what is the connection? Minerva Med 99:241\u2013251","journal-title":"Minerva Med"},{"key":"525_CR88","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1359-6101(03)00052-2","volume":"14","author":"H Ruan","year":"2003","unstructured":"Ruan H, Lodish HF (2003) Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 14:447\u2013455","journal-title":"Cytokine Growth Factor Rev"},{"key":"525_CR89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/jpet.103.065037","volume":"310","author":"RH Liu","year":"2004","unstructured":"Liu RH, Mizuta M, Matsukura S (2004) The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther 310:52\u201358","journal-title":"J Pharmacol Exp Ther"},{"key":"525_CR90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/187152707783399193","volume":"6","author":"D Carnevale","year":"2007","unstructured":"Carnevale D, De Simone R, Minghetti L (2007) Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol Disord Drug Targets 6:388\u2013397","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"525_CR91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2008.06.018","volume":"203","author":"E Nizri","year":"2008","unstructured":"Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, Brenner T (2008) Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 203:12\u201322","journal-title":"J Neuroimmunol"},{"key":"525_CR92","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/neu.2008.0516","volume":"25","author":"MV Guseva","year":"2008","unstructured":"Guseva MV, Hopkins DM, Scheff SW, Pauly JR (2008) Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury. J Neurotrauma 25:975\u2013983","journal-title":"J Neurotrauma"},{"key":"525_CR93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park HJ, Lee PH, Ahn YW, Choi YJ, Lee G, Lee DY, Chung ES, Jin BK (2007) Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci 26:79\u201389","journal-title":"Eur J Neurosci"},{"key":"525_CR94","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/jnr.20850","volume":"83","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Hide I, Matsubara A, Hama C, Harada K, Miyano K, Andra M, Matsubayashi H, Sakai N, Kohsaka S, Inoue K, Nakata Y (2006) Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C\/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res 83:1461\u20131470","journal-title":"J Neurosci Res"},{"key":"525_CR95","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.24470","volume":"60","author":"MA Maanen van","year":"2009","unstructured":"van Maanen MA, Stoof SP, van der Zanden EP, de Jonge WJ, Janssen RA, Fischer DF, Vandeghinste N, Brys R, Vervoordeldonk MJ, Tak PP (2009) The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum 60:1272\u20131281","journal-title":"Arthritis Rheum"},{"key":"525_CR96","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.23987","volume":"58","author":"JM Waldburger","year":"2008","unstructured":"Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS (2008) Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum 58:3439\u20133449","journal-title":"Arthritis Rheum"},{"key":"525_CR97","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/mol.60.6.1201","volume":"60","author":"Y Wang","year":"2001","unstructured":"Wang Y, Pereira EF, Maus AD, Ostlie NS, Navaneetham D, Lei S, Albuquerque EX, Conti-Fine BM (2001) Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol 60:1201\u20131209","journal-title":"Mol Pharmacol"},{"key":"525_CR98","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1189\/jlb.0906548","volume":"81","author":"MR Blanchet","year":"2007","unstructured":"Blanchet MR, Langlois A, Israel-Assayag E, Beaulieu MJ, Ferland C, Laviolette M, Cormier Y (2007) Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. J Leukoc Biol 81:1245\u20131251","journal-title":"J Leukoc Biol"},{"key":"525_CR99","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2353\/ajpath.2009.090212","volume":"175","author":"K Maouche","year":"2009","unstructured":"Maouche K, Polette M, Jolly T, Medjber K, Cloez-Tayarani I, Changeux JP, Burlet H, Terryn C, Coraux C, Zahm JM, Birembaut P, Tournier JM (2009) Alpha7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol 175:1868\u20131882","journal-title":"Am J Pathol"},{"key":"525_CR100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.0901808","volume":"184","author":"X Su","year":"2010","unstructured":"Su X, Matthay MA, Malik AB (2010) Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol 184:401\u2013410","journal-title":"J Immunol"},{"key":"525_CR101","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/shk.0b013e318054dd89","volume":"28","author":"IA Giebelen","year":"2007","unstructured":"Giebelen IA, van Westerloo DJ, Larosa GJ, de Vos AF, van der Poll T (2007) Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28:700\u2013703","journal-title":"Shock"},{"key":"525_CR102","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.placenta.2004.09.011","volume":"26","author":"B Xu","year":"2005","unstructured":"Xu B, Makris A, Thornton C, Hennessy A (2005) Glucocorticoids inhibit placental cytokines from cultured normal and preeclamptic placental explants. Placenta 26:654\u2013660","journal-title":"Placenta"},{"key":"525_CR103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2006.05.034","volume":"132","author":"JY Kwon","year":"2007","unstructured":"Kwon JY, Kim YH, Kim SH, Kang MH, Maeng YS, Lee KY, Park YW (2007) Difference in the expression of alpha 7 nicotinic receptors in the placenta in normal versus severe preeclampsia pregnancies. Eur J Obstet Gynecol Reprod Biol 132:35\u201339","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"525_CR104","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.placenta.2004.10.009","volume":"26","author":"KS Lips","year":"2005","unstructured":"Lips KS, Bruggmann D, Pfeil U, Vollerthun R, Grando SA, Kummer W (2005) Nicotinic acetylcholine receptors in rat and human placenta. Placenta 26:735\u2013746","journal-title":"Placenta"},{"key":"525_CR105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2007-961816","volume":"39","author":"H Kurzen","year":"2007","unstructured":"Kurzen H, Wessler I, Kirkpatrick CJ, Kawashima K, Grando SA (2007) The non-neuronal cholinergic system of human skin. Horm Metab Res 39:125\u2013135","journal-title":"Horm Metab Res"},{"key":"525_CR106","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.lfs.2006.12.028","volume":"80","author":"Y Moriwaki","year":"2007","unstructured":"Moriwaki Y, Yoshikawa K, Fukuda H, Fujii YX, Misawa H, Kawashima K (2007) Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands. Life Sci 80:2365\u20132368","journal-title":"Life Sci"},{"key":"525_CR107","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.jid.5700551","volume":"127","author":"B Favre","year":"2007","unstructured":"Favre B, Plantard L, Aeschbach L, Brakch N, Christen-Zaech S, de Viragh PA, Sergeant A, Huber M, Hohl D (2007) SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda. J Invest Dermatol 127:301\u2013308","journal-title":"J Invest Dermatol"},{"key":"525_CR108","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/hmg\/ddg320","volume":"12","author":"F Chimienti","year":"2003","unstructured":"Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, Huber M, Bertrand D, Hohl D (2003) Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet 12:3017\u20133024","journal-title":"Hum Mol Genet"},{"key":"525_CR109","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/oby.2003.74","volume":"11","author":"M Bullo","year":"2003","unstructured":"Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11:525\u2013531","journal-title":"Obes Res"},{"key":"525_CR110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4\u20137","journal-title":"Trends Immunol"},{"key":"525_CR111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.109.154633","volume":"332","author":"MB Marrero","year":"2010","unstructured":"Marrero MB, Lucas R, Salet C, Hauser TA, Mazurov A, Lippiello PM, Bencherif M (2010) An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes. J Pharmacol Exp Ther 332:173\u2013180","journal-title":"J Pharmacol Exp Ther"},{"key":"525_CR112","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pharmthera.2007.05.007","volume":"115","author":"CR Gwilt","year":"2007","unstructured":"Gwilt CR, Donnelly LE, Rogers DF (2007) The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 115:208\u2013222","journal-title":"Pharmacol Ther"},{"key":"525_CR113","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1034\/j.1398-9995.2000.00509.x-i1","volume":"56","author":"A Linneberg","year":"2001","unstructured":"Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T (2001) Smoking and the development of allergic sensitization to aeroallergens in adults: a prospective population-based study. The Copenhagen Allergy Study. Allergy 56:328\u2013332","journal-title":"Allergy"},{"key":"525_CR114","first-page":"803","volume":"31","author":"LY Chen","year":"2008","unstructured":"Chen LY, Liu ZG, Li YH, Feng YZ, Wang JR (2008) Expression of neuronal acetylcholine receptor alpha 7 (nAChRalpha7) in peripheral blood CD(4)(+) T lymphocytes from asthmatic children. Zhonghua Jie He He Hu Xi Za Zhi 31:803\u2013805","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"525_CR115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.0902227","volume":"185","author":"NC Mishra","year":"2010","unstructured":"Mishra NC, Rir-Sima-Ah J, Boyd RT, Singh SP, Gundavarapu S, Langley RJ, Razani-Boroujerdi S, Sopori ML (2010) Nicotine inhibits fc\u03c6 RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha7\/alpha9\/alpha10-nicotinic receptors. J Immunol 185:588\u2013596","journal-title":"J Immunol"},{"key":"525_CR116","doi-asserted-by":"crossref","first-page":"423241","DOI":"10.1155\/2010\/423241","volume":"2010","author":"CM Greene","year":"2010","unstructured":"Greene CM, Ramsay H, Wells RJ, O\u2019Neill SJ, McElvaney NG (2010) Inhibition of Toll-like receptor 2-mediated interleukin-8 production in cystic fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptor. Mediators Inflamm 2010:423241","journal-title":"Mediators Inflamm"},{"key":"525_CR117","doi-asserted-by":"crossref","first-page":"L1139","DOI":"10.1152\/ajplung.00406.2004","volume":"288","author":"G Dorion","year":"2005","unstructured":"Dorion G, Israel-Assayag E, Beaulieu MJ, Cormier Y (2005) Effect of 1, 1-dimethylphenyl 1,4-piperazinium on mouse tracheal smooth muscle responsiveness. Am J Physiol Lung Cell Mol Physiol 288:L1139\u2013L1145","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"525_CR118","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00011-008-8070-1","volume":"57","author":"P Zhang","year":"2008","unstructured":"Zhang P, Han D, Tang T, Zhang X, Dai K (2008) Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res 57:322\u2013328","journal-title":"Inflamm Res"},{"key":"525_CR119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/art.24177","volume":"60","author":"MA Maanen van","year":"2009","unstructured":"van Maanen MA, Lebre MC, van der Poll T, Larosa GJ, Elbaum D, Vervoordeldonk MJ, Tak PP (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 60:114\u2013122","journal-title":"Arthritis Rheum"},{"key":"525_CR120","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1136\/ard.2009.118554","volume":"69","author":"MA Maanen van","year":"2010","unstructured":"van Maanen MA, Stoof SP, Larosa GJ, Vervoordeldonk MJ, Tak PP (2010) Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann Rheum Dis 69:1717\u20131723","journal-title":"Ann Rheum Dis"},{"key":"525_CR121","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","volume":"43","author":"YC Chung","year":"2010","unstructured":"Chung YC, Ko HW, Bok E, Park ES, Huh SH, Nam JH, Jin BK (2010) The role of neuroinflammation on the pathogenesis of Parkinson\u2019s disease. BMB Rep 43:225\u2013232","journal-title":"BMB Rep"},{"key":"525_CR122","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharm Des 11:999\u20131016","journal-title":"Curr Pharm Des"},{"key":"525_CR123","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","volume":"57","author":"Y Ouchi","year":"2005","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease. Ann Neurol 57:168\u2013175","journal-title":"Ann Neurol"},{"key":"525_CR124","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1447-0756.2008.00826.x","volume":"34","author":"LC Ajonuma","year":"2008","unstructured":"Ajonuma LC, Chan PK, Ng EH, Fok KL, Wong CH, Tsang LL, Tang XX, Ho LS, Lau MC, Chung CM, He Q, Huang HY, Yang DZ, Rowlands DK, Chung YW, Chan HC (2008) Involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in the pathogenesis of hydrosalpinx induced by Chlamydia trachomatis infection. J Obstet Gynaecol Res 34:923\u2013930","journal-title":"J Obstet Gynaecol Res"},{"key":"525_CR125","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2174\/138161207780858429","volume":"13","author":"H Wilms","year":"2007","unstructured":"Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R (2007) Inflammation in Parkinson\u2019s diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des 13:1925\u20131928","journal-title":"Curr Pharm Des"},{"key":"525_CR126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","volume":"116","author":"L Zecca","year":"2008","unstructured":"Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R (2008) Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson\u2019s disease. Acta Neuropathol 116:47\u201355","journal-title":"Acta Neuropathol"},{"key":"525_CR127","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","volume":"23","author":"M Quik","year":"2008","unstructured":"Quik M, O\u2019Leary K, Tanner CM (2008) Nicotine and Parkinson\u2019s disease: implications for therapy. Mov Disord 23:1641\u20131652","journal-title":"Mov Disord"},{"key":"525_CR128","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-3083.2009.02266.x","volume":"70","author":"M Westman","year":"2009","unstructured":"Westman M, Engstrom M, Catrina AI, Lampa J (2009) Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand J Immunol 70:136\u2013140","journal-title":"Scand J Immunol"},{"key":"525_CR129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"LV Borovikova","year":"2000","unstructured":"Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458\u2013462","journal-title":"Nature"},{"key":"525_CR130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SHK.0b013e3181a551bd","volume":"32","author":"H Wang","year":"2009","unstructured":"Wang H, Ward MF, Sama AE (2009) Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32:348\u2013357","journal-title":"Shock"},{"key":"525_CR131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","volume":"11","author":"L Ulloa","year":"2005","unstructured":"Ulloa L, Tracey KJ (2005) The \u201ccytokine profile\u201d: a code for sepsis. Trends Mol Med 11:56\u201363","journal-title":"Trends Mol Med"},{"key":"525_CR132","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nm1124","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216\u20131221","journal-title":"Nat Med"},{"key":"525_CR133","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20052362","volume":"203","author":"JM Huston","year":"2006","unstructured":"Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, Pavlov VA, Gallowitsch-Puerta M, Ashok M, Czura CJ, Foxwell B, Tracey KJ, Ulloa L (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203:1623\u20131628","journal-title":"J Exp Med"},{"key":"525_CR134","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2249.2006.03248.x","volume":"147","author":"X Wittebole","year":"2007","unstructured":"Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF (2007) Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 147:28\u201334","journal-title":"Clin Exp Immunol"},{"key":"525_CR135","doi-asserted-by":"crossref","first-page":"E686","DOI":"10.1152\/ajpendo.90263.2008","volume":"295","author":"M Clodi","year":"2008","unstructured":"Clodi M, Vila G, Geyeregger R, Riedl M, Stulnig TM, Struck J, Luger TA, Luger A (2008) Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am J Physiol Endocrinol Metab 295:E686\u2013E691","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"525_CR136","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.sla.0000251614.42290.ed","volume":"245","author":"R Wu","year":"2007","unstructured":"Wu R, Dong W, Cui X, Zhou M, Simms HH, Ravikumar TS, Wang P (2007) Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 245:480\u2013486","journal-title":"Ann Surg"},{"key":"525_CR137","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.CCM.0B013E31816208B3","volume":"36","author":"S Hofer","year":"2008","unstructured":"Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA (2008) Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 36:404\u2013408","journal-title":"Crit Care Med"},{"key":"525_CR138","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3949\/ccjm.69.8.621","volume":"69","author":"JM Wolf","year":"2002","unstructured":"Wolf JM, Lashner BA (2002) Inflammatory bowel disease: sorting out the treatment options. Cleve Clin J Med 69:621\u2013631","journal-title":"Cleve Clin J Med"},{"key":"525_CR139","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.3748\/wjg.v12.i46.7451","volume":"12","author":"DA Scott","year":"2006","unstructured":"Scott DA, Martin M (2006) Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases. World J Gastroenterol 12:7451\u20137459","journal-title":"World J Gastroenterol"},{"key":"525_CR140","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ibd.20020","volume":"13","author":"VE McGilligan","year":"2007","unstructured":"McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR (2007) Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. Inflamm Bowel Dis 13:108\u2013115","journal-title":"Inflamm Bowel Dis"},{"key":"525_CR141","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/ibd.20523","volume":"14","author":"MC Aldhous","year":"2008","unstructured":"Aldhous MC, Prescott RJ, Roberts S, Samuel K, Waterfall M, Satsangi J (2008) Does nicotine influence cytokine profile and subsequent cell cycling\/apoptotic responses in inflammatory bowel disease? Inflamm Bowel Dis 14:1469\u20131482","journal-title":"Inflamm Bowel Dis"},{"key":"525_CR142","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2006.08.016","volume":"131","author":"JE Ghia","year":"2006","unstructured":"Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM (2006) The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131:1122\u20131130","journal-title":"Gastroenterology"},{"key":"525_CR143","doi-asserted-by":"crossref","first-page":"G560","DOI":"10.1152\/ajpgi.00098.2007","volume":"293","author":"JE Ghia","year":"2007","unstructured":"Ghia JE, Blennerhassett P, Collins SM (2007) Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 293:G560\u2013G567","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"525_CR144","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1566-0702(03)00023-7","volume":"105","author":"PC Miceli","year":"2003","unstructured":"Miceli PC, Jacobson K (2003) Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Auton Neurosci 105:16\u201324","journal-title":"Auton Neurosci"},{"key":"525_CR145","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-3083.2007.02011.x","volume":"66","author":"A Bai","year":"2007","unstructured":"Bai A, Guo Y, Lu N (2007) The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol 66:538\u2013545","journal-title":"Scand J Immunol"},{"key":"525_CR146","first-page":"2209","volume":"118","author":"JE Ghia","year":"2008","unstructured":"Ghia JE, Blennerhassett P, Collins SM (2008) Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 118:2209\u20132218","journal-title":"J Clin Invest"},{"key":"525_CR147","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/00001756-200507130-00018","volume":"16","author":"A Orr-Urtreger","year":"2005","unstructured":"Orr-Urtreger A, Kedmi M, Rosner S, Karmeli F, Rachmilewitz D (2005) Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport 16:1123\u20131127","journal-title":"Neuroreport"},{"key":"525_CR148","doi-asserted-by":"crossref","first-page":"44920","DOI":"10.1074\/jbc.M204610200","volume":"277","author":"S Shaw","year":"2002","unstructured":"Shaw S, Bencherif M, Marrero MB (2002) Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1\u201342) amyloid. J Biol Chem 277:44920\u201344924","journal-title":"J Biol Chem"},{"key":"525_CR149","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2249.2006.03169.x","volume":"146","author":"H Yoshikawa","year":"2006","unstructured":"Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, Suzuki N (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116\u2013123","journal-title":"Clin Exp Immunol"},{"key":"525_CR150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00384-006-0135-4","volume":"22","author":"T Spoettl","year":"2007","unstructured":"Spoettl T, Paetzel C, Herfarth H, Bencherif M, Schoelmerich J, Greinwald R, Gatto GJ, Rogler G (2007) (E)-metanicotine hemigalactarate (TC-2403\u201312) inhibits IL-8 production in cells of the inflamed mucosa. Int J Colorectal Dis 22:303\u2013312","journal-title":"Int J Colorectal Dis"},{"key":"525_CR151","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2005.05.007","volume":"166","author":"LC Gahring","year":"2005","unstructured":"Gahring LC, Days EL, Kaasch T, de Gonzalez MM, Owen L, Persiyanov K, Rogers SW (2005) Pro-inflammatory cytokines modify neuronal nicotinic acetylcholine receptor assembly. J Neuroimmunol 166:88\u2013101","journal-title":"J Neuroimmunol"},{"key":"525_CR152","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.lfs.2007.02.005","volume":"80","author":"MV Skok","year":"2007","unstructured":"Skok MV, Grailhe R, Agenes F, Changeux JP (2007) The role of nicotinic receptors in B-lymphocyte development and activation. Life Sci 80:2334\u20132336","journal-title":"Life Sci"},{"key":"525_CR153","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.taap.2009.10.020","volume":"242","author":"SC Oloris","year":"2010","unstructured":"Oloris SC, Frazer-Abel AA, Jubala CM, Fosmire SP, Helm KM, Robinson SR, Korpela DM, Duckett MM, Baksh S, Modiano JF (2010) Nicotine-mediated signals modulate cell death and survival of T lymphocytes. Toxicol Appl Pharmacol 242:299\u2013309","journal-title":"Toxicol Appl Pharmacol"},{"key":"525_CR154","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.archoralbio.2008.11.006","volume":"54","author":"S Nakao","year":"2009","unstructured":"Nakao S, Ogata Y, Sugiya H (2009) Nicotine stimulates the expression of cyclooxygenase-2 mRNA via NFkappaB activation in human gingival fibroblasts. Arch Oral Biol 54:251\u2013257","journal-title":"Arch Oral Biol"},{"key":"525_CR155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5246\/jcps.2010.03.028","volume":"19","author":"F Xiao","year":"2010","unstructured":"Xiao F, Zhu J, Zhao L, Zheng G, Yang A, Tao J, Zhang B, Huang Z, Xiong F (2010) Involvement of pro-inflammatory and anti-inflammatory cytokines in the anti-inflammatory activity of Rubus idaeus L. on LPS-treated RAW 264.7 cells. J Chin Pharm Sci 19:201\u2013208","journal-title":"J Chin Pharm Sci"},{"key":"525_CR156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2353\/ajpath.2008.070529","volume":"172","author":"M Martinez-Ferrer","year":"2008","unstructured":"Martinez-Ferrer M, Iturregui JM, Uwamariya C, Starkman J, Sharif-Afshar AR, Suzuki K, Visedsindh W, Matusik RJ, Dmochowski RR, Bhowmick NA (2008) Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. Am J Pathol 172:59\u201367","journal-title":"Am J Pathol"},{"key":"525_CR157","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/jnr.21604","volume":"86","author":"N Sawe","year":"2008","unstructured":"Sawe N, Steinberg G, Zhao H (2008) Dual roles of the MAPK\/ERK1\/2 cell signaling pathway after stroke. J Neurosci Res 86:1659\u20131669","journal-title":"J Neurosci Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-010-0525-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0525-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T10:53:18Z","timestamp":1711882398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-010-0525-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,15]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s00018-010-0525-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,15]]}}}